China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Gecacitinib to Treat Low-Risk Myelodysplastic Syndrome (MDS) with Anemia'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129451
Registration Time: 2026/08/05
Type: Interventional study
Primary Sponsor: The FIrst Affiliated Hospital, College of Medicine, Zhejiang University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334459
Published by HT Digital Content Services with permission from Health Daily Digest....